ANJU GEEVARGHESE: Open Payments
NPI 1972002962 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 22 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $709 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $173 |
| Novo Nordisk Inc | 4 | $77 |
| Cipher Pharmaceuticals US LLC | 1 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $18 |
Products named: JARDIANCE, OTEZLA, Ozempic, Natroba, REPATHA, Kerendia, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
